ImExHS Limited (IME.AX)
ImExHS Limited operates in the Medical - Healthcare Information Services industry of the Healthcare sector, headquartered in Sydney, NSW, AU. The stock last traded at $0.32, down 0.00% on the session, giving a market capitalisation of $17.4M. Its beta of 0.81 implies it has historically moved less than the broad market.
ImExHS Limited delivers cloud-powered medical imaging technologies to customers worldwide, including those in Australia. The firm specializes in the development and sale of modular imaging software systems, which encompass comprehensive information management platforms for disciplines such as radiology, cardiology, and pathology, alongside a robust picture archiving and communication system (PACS). Its principal software solutions include AQUILA for radiology, ALULA for pathology, and Antero for cardiology. Moreover, ImExHS offers STELLA.I, a suite of artificial intelligence tools hosted in the cloud, crafted to bolster diagnostic capabilities for medical professionals. The company further extends outsourced radiology and teleradiology services to hospitals and various other healthcare entities. Established in 2001, ImExHS Limited operates from its base in Mascot, Australia.
ImExHS Limited is most often compared with the following Healthcare names: